arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Bluejay Diagnostics, Inc.

BJDX

$1.05 ▼ -0.06 (-5.41%) at close

26 Visible periods

21 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Bluejay Diagnostics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.0M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -36.6% ↘

FCF / Share $-1.63

Trailing P/E —

Price / Book 0.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-1.92M

↓ -2.9% —

FCF / Share Free cash flow per share

$-1.63

↑ +23.6% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
EPS Growth YoY (%)	42.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	93.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-531.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	72.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-240.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	95.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	92.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-86.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-725.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-151302.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-1286.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-2650.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	-2522.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	33.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-2.9% Weak ↓ Weak Declining Year-over-year change in net income	0.2% Caution ↓ Caution Declining Year-over-year change in net income	19.9% Good ↓ Good Declining Year-over-year change in net income	19.9% Good ↓ Good Declining Year-over-year change in net income	19.9% Good ↑ Good Improving Year-over-year change in net income	37.8% Excellent ↑ Excellent Improving Year-over-year change in net income	8.3% Fair ↑ Fair Improving Year-over-year change in net income	8.3% Fair ↑ Fair Improving Year-over-year change in net income	8.3% Fair ↑ Fair Improving Year-over-year change in net income	3.5% Caution ↑ Caution Improving Year-over-year change in net income	-26.1% Weak ↑ Weak Improving Year-over-year change in net income	-26.1% Weak ↑ Weak Improving Year-over-year change in net income	-26.1% Weak ↑ Weak Improving Year-over-year change in net income	-63.4% Weak ↑ Weak Improving Year-over-year change in net income	-68.7% Weak ↑ Weak Improving Year-over-year change in net income	-936.8% Weak ↓ Weak Declining Year-over-year change in net income	-936.8% Weak ↓ Weak Declining Year-over-year change in net income	-168.5% Weak Weak Year-over-year change in net income	-832.4% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	23.6% Good Good Year-over-year change in free cash flow	—	—	—	-116.4% Weak Weak Year-over-year change in free cash flow	—	—	—	-514.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
FCF / Net Income (x)	0.84x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	—	1.00x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	1.24x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	1.29x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.33x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.96x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.74x Excellent ↓ Excellent Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.83x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.92x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.28x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-36.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-34.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-38.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-57.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-65.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-36.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	70.0% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	426.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	4.3% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	10.9% Good Good Return earned on debt + equity capital invested Optimal: > 10%	3.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-34.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-20.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-33.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-31.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-35.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-17.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-49.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-34.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-24.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-26.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-38.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-45.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-406%)	-23.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	-50.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-437%)	-35.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-335%)	-48.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-421%)	-25.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-267%)	-32.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-317%)	-26.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-280%)	-69.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-561%)	-79.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-630%)	-48.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-425%)	-39.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-366%)	-27.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-285%)	-20.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-238%)	-14.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-197%)	-12.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-181%)	-10.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-7.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	110.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+636%)	157.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+948%)	4.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-70%)	12.9% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-14%)	3.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	-7.32x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—	—	—	—	-17.74x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-28.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-116.02x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-23.45x Weak Weak Operating income divided by interest expense Optimal: > 5x	-14.97x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-3.68M	$-5.16M	$-3.08M	$-4.44M	$-3.12M	$-4.30M	$-5.76M	$-8.06M	$-2.66M	$-2.21M	$-5.08M	$-5.10M	$-6.78M	$-10.11M	$-13.29M	$-15.34M	$-17.12M	$-19.05M	$-2.33M	—	—	$-912.36K	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.01	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.95	$-10.63	$-1.01	$-1.41	$-3.37	$-173.57	$-0.16	$-5.12	$-0.99	$-3.57K	$-2.08	$-2.75	$-0.12	$-2.36	$-0.15	$-0.10	—	$-0.09	—	$-0.15	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.63	—	$-0.86	$-1.48	$-2.14	—	—	—	$-0.99	—	—	—	$-0.16	—	—	—	—	—	—	$-0.08	—	—	—	—	—	—
Book Value per Share (USD)	$4.04	$9.88	$2.25	$3.54	$6.98	$41.37	$0.40	$3.34	$1.25	—	$4.21	$6.23	$0.45	$11.42	$0.69	$0.83	$0.92	$1.01	$-0.10	$-0.03	—	$-1.34	—	—	—	—
Tangible Book Value per Share (USD)	$4.04	$9.88	$2.25	$3.54	$6.98	$41.37	$0.40	$3.34	$1.25	—	$4.21	$6.23	$0.45	$11.42	$0.69	$0.83	$0.92	$1.01	$-0.10	$-0.03	—	$-1.34	—	—	—	—
Basic Weighted Avg Shares (shares)	984,668	—	1.57M	1.39M	554,012	—	9.56M	483,164	2.36M	—	1.10M	1.02M	20.38M	—	20.15M	20.15M	—	—	—	4.20M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$2.55M	$4.34M	$2.20M	$3.71M	$2.26M	$4.09M	$5.52M	$6.96M	$1.92M	$1.45M	$3.73M	$4.75M	$7.48M	$10.15M	$12.41M	$16.07M	$18.01M	$20.02M	—	—	—	—	—	—	—	—
Total Equity (USD)	$4.18M	$5.98M	$3.69M	$5.29M	$3.87M	$5.73M	$7.16M	$8.64M	$3.37M	$2.89M	$5.21M	$6.38M	$9.16M	$11.54M	$13.81M	$16.66M	$18.49M	$20.38M	$-1.08M	$-123.48K	$-4.30M	$-4.21M	$-3.74M	$-3.55M	$-3.31M	$-2.93M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	$249.04K	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$27.76K	$27.41K	$10.62K	$17.74K	$18.40K	$19.77K	—	—	$19.71K	$22.34K	—	—	$120.02K	$30.68K	—	—	—	—	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-1.92M	$-1.43M	$-1.86M	$-1.86M	$-1.86M	$-1.43M	$-2.33M	$-2.33M	$-2.33M	$-2.30M	$-2.54M	$-2.54M	$-2.54M	$-2.39M	$-2.01M	$-2.01M	$-2.01M	$-1.46M	$-1.19M	$-194.19K	$-194.19K	$-544.02K	$-127.99K	—	—	—
Operating Cash Flow (USD)	$-1.59M	$-1.45M	$-1.36M	$-2.05M	$-1.18M	$-1.45M	—	—	$-2.30M	$-2.78M	—	—	$-2.93M	$-2.94M	—	—	$-1.88M	$-2.52M	—	$-356.18K	$-372.62K	$-154.86K	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Bluejay Diagnostics, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BJDX with peers